Ratings Careium AB

Equities

CARE

SE0017131824

Delayed Nasdaq Stockholm 09:30:35 2024-05-24 EDT 5-day change 1st Jan Change
30.9 SEK -0.32% Intraday chart for Careium AB -2.22% +33.77%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • With regards to fundamentals, the enterprise value to sales ratio is at 0.99 for the current period. Therefore, the company is undervalued.
  • The company appears to be poorly valued given its net asset value.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

Weaknesses

  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.

Ratings chart - Surperformance

Sector: Business Support Services

1st Jan change Capi. Investor Rating ESG Refinitiv
+33.77% 70.23M -
-1.33% 13.44B
C+
+16.40% 6.07B
B-
-28.01% 1.89B -
D+
-2.27% 1B
B+
-3.17% 837M
B
-8.36% 733M
C
+54.72% 525M - -
+3.72% 498M - -
+13.34% 266M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality